MedPath

Exercise Rehabilitation Trial in Huntington*s disease

Phase 2
Completed
Conditions
Huntington's disease
10028037
Registration Number
NL-OMON40355
Lead Sponsor
Cardiff University, Cardiff, UK
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
8
Inclusion Criteria

1) diagnosis of manifest HD, confirmed by genetic testing
2) above the age of 18
3) stable medication regime for four weeks prior to initiation of trial, and anticipated to be able to
maintain a stable regime for the course of trial
4) enrolled in EHDN Registry study

Exclusion Criteria

1) any physical or psychiatric condition that would prohibit the participant from completing the
intervention or the full battery of assessments
2) inability to independently use the exercise bike
3) unable to understand or communicate in spoken English (UK sites only)
4) currently involved in any intervention trial or within four weeks of completing an intervention trial
5) current, regular participation in a structured exercise programme five times per week or more

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath